Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Bristol-Pfizer Anticlotting Drug Gets Key EU Approval

A state-of-the-art antiblood-clotting drug developed by Bristol-Myers Squibb (NYSE: BMY  ) and Pfizer (NYSE: PFE  ) has won a second, crucial approval for sale in the European Union, the companies announced Tuesday in a joint press release.

The European Commission gave the nod to Eliquis, the companies' brand name for apixaban, for use by patients suffering from atrial fibrillation. This condition is the irregular, rapid contraction of fibers in the heart muscle, and is one of the leading causes of improper clotting and thus stroke.

Eliquis, which thins the blood as a means of fighting such clotting, had previously been approved for sale in the EU only for the prevention of deep-vein clotting in patients recovering from hip or knee replacement surgery. The new approval significantly widens the market for the drug. According to the two companies, around 6 million Europeans are afflicted with atrial fibrillation.

Eliquis belongs to a new generation of anticlotting drugs aiming to supplant the existing standard, warfarin. Although the latter is effective and inexpensive, it requires constant blood testing in order to monitor proper dosage.

Eliquis has not yet been approved by the U.S. Food and Drug Administration. After two delays, the regulator has said it will hand down a decision by March 17.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2123124, ~/Articles/ArticleHandler.aspx, 10/25/2016 1:00:10 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 3 hours ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:01 PM
BMY $49.23 Down -0.79 -1.58%
Bristol-Myers Squi… CAPS Rating: ****
PFE $32.13 Down -0.05 -0.16%
Pfizer CAPS Rating: ****